Bernstein Slashes PB Fintech Price Target by 53% on Health Unit Concerns

Bernstein has cut its price target for PB Fintech by 53%, signaling fresh concerns about the profitability of the company's health insurance operations. The downgrade reflects mounting losses in the health business segment, which the research firm says has been unprofitable since inception.

According to Bernstein's analysis, PB Fintech's health insurance unit posted losses in its first year of operations. The company has been absorbing these losses through aggressive customer acquisition and high commission rates charged to insurers, alongside high-margin renewal premiums that generate ongoing revenue.

The structural challenge facing the business model has prompted Bernstein to suggest that PB Fintech may need to consider becoming a licensed insurance company itself, rather than operating purely as a distribution platform. Such a move would represent a significant strategic shift and would require substantial capital allocation and regulatory approval.

PB Fintech, which operates the PolicyBazaar and PaisaBazaar brands, has faced investor scrutiny over unit economics and path to profitability in recent quarters. The health insurance segment represents a key growth area for the company, but the mounting losses have raised questions about the sustainability of its current business model in that vertical.

The revised target price comes as the company navigates a challenging operating environment marked by increased competition in the insurtech space and evolving regulatory requirements for digital insurance distribution in India.